Reading Time: 2 minutesIntroduction Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has been increasingly recognized for its potential in managing type 2 diabetes and obesity. Its role in enhancing insulin sensitivity, particularly in American males, has garnered significant attention in the medical community. …